We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Image: A four‑protein signature can identify pediatric IBD and distinguish its subtypes (Image credit: iStock)

Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes

A new four-protein blood test identifies pediatric IBD and distinguishes Crohn's from ulcerative colitis noninvasively. More...
25 Jun 2026
Image: New findings indicate that chimeric RNAs, once viewed as cancer byproducts, can also be part of normal physiology with regulatory functions (Image credit: Adobe Stock)

Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease

Researchers identify a female-specific chimeric RNA that tracks COVID-19 severity, informing blood-based risk stratification. More...
25 Jun 2026
Image: Blue represents nuclei and pink represents dead or dying cells. Bottom right: Cells are overexpressing the BIRC3 variant which is seen in green. (Photo courtesy of The Hospital for Sick Children)

Genetic Marker Supports Anti-TNF Therapy Selection in Crohn’s Disease

New findings identify Crohn’s-linked genetic changes that may help stratify patients and guide anti-TNF therapy. More...
25 Jun 2026
Image: An uncertainty‑aware framework strengthens AI reliability for cancer histology subtyping (Image credit: Shutterstock)

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping

An uncertainty-aware AI approach boosts pathology, flagging out-of-scope inputs and meeting accuracy targets in cancer subtyping. More...
25 Jun 2026
Image: Volition’s Nu.Q NETs test detects markers associated with neutrophil extracellular traps, which are released during NETosis and linked to sepsis and other acute and chronic disorders (Image credit: iStock)

Collaboration Aims to Broaden Access to NETosis-Linked Disease Testing

VolitionRx announced a collaboration with Sysmex Corporation to optimize Volition’s Nu.Q NETs H3.1 assay on the Sysmex platform.  More...
25 Jun 2026
Image: Findings showed that the Stockholm3 blood test detected more clinically significant prostate cancers than PSA testing without increasing unnecessary testing (Image credit: 123RF)

Blood Test Detects More High-Risk Prostate Cancers Than PSA

A new blood test detects more aggressive prostate cancers than PSA without increasing unnecessary testing. More...
24 Jun 2026
Image: Biomarker testing is critical for lung cancer therapy selection, yet ordering delays mean biopsy-to-result turnaround still averages about 27 days, according to a new study (image credit: Shutterstock)

Study Highlights Biomarker Testing Delays in Lung Cancer Care

New findings highlight ordering delays as main driver of 27-day biopsy-to-biomarker turnaround, risking delayed targeted therapy. More...
24 Jun 2026
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Thyroid Test
Anti-Thyroid EIA Test
Copyright © 2000-2026 Globetech Media. All rights reserved.